Background: In present study colposcopic evaluation of unhealthy cervix was donr and it’s correlation with Papanicolau smear in screening of Cancer cervix. Objective of present study was to critically evaluate the sensitivity and specificity of PAP smear with that of Colposcopy in screening of Cancer Cervix in women with unhealthy cervix.Methods: 100 women with clinically unhealthy cervix on naked eye examination and / or abnormal symptoms attending Gynaecology Out patient department in 2 years period were subjected to PAP smear, Colposcopy, biopsies under Colposcopic guidance and findings correlated with Histopatholgy at Govt. Medical college, Aurangabad, Maharashtra. India. The sensitivity and specificity of PAP smear with that of Colposcopy in screening of Cancer Cervix was evaluated.Results: Both PAP smear and Colposcopy can be reliably used to screen women with premalignant lesions of Cancer cervix.Conclusions: Colposcopy is a better tool for diagnosis of precursors of Cancer Cervix than PAP Smear and Histopathology of suspected lesion remains the gold standard for final diagnosis.
Surgery is like hunting, if you are going for a rabbit, be ready to face a tiger. Abdomen is like a magic box, clinicians suspect one thing, radiologists conclude other thing and surgeons surprise us by extracting something else. CASE REPORT: A 35 years old 1,2 female, Para 3 Living 3 with tubectomy done 12 years back having all full term vaginal deliveries came with chief complaints of pain in abdomen and discomfort in vagina since 4 months. There was no history of any menstrual or bowel, bladder complaints. General and systemic examinations were within normal limits. On per abdominal examination liver and spleen were not palpable, umbilicus was in normal position, and there was a firm mass arising from pelvis about 18 weeks' pregnancy size, mobile, non-tender, no evidence of ascites. On per speculum examination, cervix was taken up and not visualized. There was bogginess in posterior fornix of vagina. On per vaginal examination, cervix was pinpoint ; retro pubic and taken up, about 18 weeks' pregnancy size mass was felt. The movements of mass were transmitted to cervix; uterus could not be made out separately. Her lab profile values were within normal limits with hemoglobin 10.5 gm%. On ultrasonography findings 3 there was huge isoechoic mass of size 112 x 80 millimeters occupying right pelvic region and extending upwards probably arising from right ovary, uterus normal, and left ovary normal-findings suggestive of ? Right ovarian dermoid. 4 On computed tomography, right ovary showed well defined circular lesion of 115 x 105 millimeter with regular borders without calcification, uterus-normal, left ovary-normal-findings suggestive of right Ovarian Dermoid Cyst. 4
Gas gangrene in pregnancy is a rare occurrence although associated with high mortality. We report the case of a patient who developed gas gangrene of abdominal wall post-partum. A 30-year-old G3P2L2 with 6 months of amenorrhea, a neglected ANC with no antenatal visits, a known case of quadriparesis, delivered a preterm male baby. Having a contusion of 20*10cm size on lower abdomen, a blister formed over the same post-partum which had to be debrided. She was treated vigorously with antibiotics and tetanus antitoxin; and appropriate supportive management. Patient’s condition worsened after 36hrs and 46 hrs after admission she went into cardiac arrest. And such we encountered a case in 2019 in modern-day obstetrics, of gas gangrene complicating pregnancy, costing life to both the new-born and parturient. The importance of early suspicion and diagnosis followed by prompt, vigorous treatment cannot be emphasized more.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.